Long-Term Clinical Outcomes of a Phase I Trial of Intravesical Docetaxel in the Management of Non–muscle-Invasive Bladder Cancer Refractory to Standard Intravesical Therapy
Urology - United States
doi 10.1016/j.urology.2009.06.112
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 1, 2010
Authors
Publisher
Elsevier BV